The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Does Mounjaro Fatigue Go Away Over Time?
Fatigue is a commonly reported side effect when starting Mounjaro (tirzepatide), but many people find it improves as their body adjusts to the medication. In this guide, we explore whether Mounjaro-related tiredness typically resolves, how it compares to Wegovy, and what clinical trial data tells us about managing fatigue whilst on a GLP-1 or dual GIP/GLP-1 injection. If you're considering either medication, understanding what to expect from side effects is important for your decision-making process.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Mounjaro Fatigue vs Wegovy: What the Trial Data Shows
Fatigue was reported in clinical trials for both Mounjaro and Wegovy, though rates and patterns differ slightly. In the SURMOUNT-1 trial for Mounjaro (tirzepatide), fatigue was reported as a common side effect affecting approximately 5–10% of participants. In the STEP trials for Wegovy (semaglutide), fatigue occurred at similar rates. Importantly, most fatigue-related symptoms were mild to moderate and decreased over time as participants continued treatment—particularly after the first 4–8 weeks.
Key differences between the medications:
- Mounjaro is a dual GIP and GLP-1 receptor agonist, meaning it activates two hormone pathways simultaneously
- Wegovy is a GLP-1 receptor agonist only—single mechanism of action
- The dual mechanism in Mounjaro may theoretically affect energy metabolism differently, though clinical trial fatigue rates remain comparable
- Both require gradual dose titration (stepping up doses over weeks), which helps your body adjust and may reduce fatigue severity
Individual experiences vary significantly. Some people experience no fatigue at all, whilst others notice it early on but see improvement within 4–6 weeks as their body adapts.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Managing Fatigue and Choosing Between Mounjaro and Wegovy
If you experience fatigue when starting either Mounjaro or Wegovy, several strategies may help. Ensure you're eating enough calories—a common mistake is restricting calories too aggressively alongside the medication's appetite-suppressing effects, which can amplify tiredness. Stay hydrated, maintain regular gentle physical activity, and get adequate sleep. If fatigue persists beyond 8–12 weeks or severely impacts your daily life, inform your prescriber—they may adjust your dose or medication.
Both medications are prescription-only and require a clinical assessment before prescribing. A UK-licensed prescriber will evaluate which option suits your individual health profile, medical history, and side effect tolerance. Use our free GLP-1 weight loss calculator to explore projected outcomes with each medication, and discuss specific concerns about fatigue during your consultation. Your prescriber can provide personalised guidance based on your unique circumstances.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Does Mounjaro fatigue go away after a few weeks?
In most cases, yes. Clinical trial data shows that fatigue reported early in treatment typically improves within 4–8 weeks as your body adjusts to the medication. However, individual timelines vary—some people see improvement sooner, whilst others may take longer. If fatigue persists beyond 12 weeks or affects your daily life significantly, discuss this with your prescriber.
Is fatigue worse with Mounjaro than with Wegovy?
Clinical trials show comparable fatigue rates between Mounjaro and Wegovy—around 5–10% of participants reported it. The dual GIP/GLP-1 mechanism of Mounjaro doesn't appear to cause significantly more fatigue than Wegovy's single GLP-1 mechanism. Individual responses vary more than the medication type. Your prescriber will help determine which is more suitable for you.
What should I do if fatigue is severe when taking Mounjaro?
Severe fatigue may indicate you need a dose adjustment, slower titration, or even a medication switch. Contact your prescriber promptly rather than stopping the medication abruptly. Common causes include undereating (the injection suppresses appetite, but you still need adequate calories) or dehydration. Your prescriber can advise on adjustments.
Can I take Mounjaro if I have a history of fatigue or low energy?
A history of fatigue doesn't automatically rule out Mounjaro, but it's important to discuss with your prescriber during your clinical assessment. They'll review your medical history, current medications, and energy patterns to decide if Mounjaro or Wegovy is more appropriate, or suggest monitoring strategies.
Does the Mounjaro KwikPen dose you're on affect how much fatigue you experience?
Yes, fatigue is often dose-dependent. Lower starting doses (2.5 mg) typically cause less fatigue than higher maintenance doses. Your prescriber uses a gradual dose titration schedule to allow your body to adjust. If fatigue increases at a higher dose, your prescriber may slow the titration or consider an alternative approach.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.